Sanofi blueprints major vaccine production expansion

Sanofi Pasteur has blueprinted plans for a major new vaccine facility in Neuville-sur-Saône, Rhône, France, where the new vaccine against the dengue fever is already planned to be produced. This plant will become the group's third largest European center fully dedicated to vaccines by 2014. Report

Suggested Articles

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.

Takeda has spent considerable resources on its phase 3 dengue vaccine, and now data show the shot was 80% effective in preventing dengue.